Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
about
Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting DrugComparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysisEffect of vildagliptin on hepatic steatosis.Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical TrialImproved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.Non-alcoholic fatty liver disease and diabetes.A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs.Vildagliptin reduces plasma stromal cell-derived factor-1α in patients with type 2 diabetes compared with glimepiride.A review of gliptins for 2014.Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.Network meta-analysis of lorcaserin and oral hypoglycaemics for patients with type 2 diabetes mellitus and obesity.
P2860
Q27301094-37E4B7A7-ED92-4FFD-A25F-1E5BB5863C92Q28546797-BAE8167A-8B94-4153-AF15-D14C760F3F21Q35442079-220729B8-5F51-426D-BAB8-103A5A80EA06Q35916952-CD82833A-6B93-483A-A433-FEA5084C342CQ35928257-4DE8AD35-FA2D-44CB-9989-714342FD2A90Q37091659-08B6C751-2021-4559-BB20-070F3CE9AE2DQ37610459-89AB829B-FE7D-4ADC-A302-4C04F4FD3617Q37677889-2243D237-4626-4DAF-870D-40B3903D86A7Q38266290-8B61CBC3-742D-48B3-9190-A62317DF161BQ38682317-09A20DD3-A960-4221-90EF-1027894B5643Q43159888-8E338BA6-8990-472C-99C2-B5B9E0C90EF0Q50168195-8804A323-ADF1-4C9C-83F4-0E0D48A51AA8
P2860
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@en
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@nl
type
label
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@en
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@nl
prefLabel
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@en
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@nl
P2093
P1433
P1476
Vildagliptin compared to glime ...... e in type 2 diabetic patients.
@en
P2093
Aldo Bonaventura
Angela D'Angelo
Davide Romano
Elena Fogari
Lucio Bianchi
P304
P356
10.1016/J.METABOL.2014.04.008
P577
2014-04-23T00:00:00Z